Collaborating on therapeutic development: opportunities available

At the 2019 Therapeutic Development Workshop, experts shared perspectives on the challenges of moving a therapy from basic research discovery to the clinic. Opportunities still exist to continue the valuable discussion.

Christina Kingen | 11 Jun 2020

Led by UNSW Medicine and funded by the Cancer Theme (and Maridulu Budyari Gumal (SPHERE) Cancer CAG, the workshop enabled experts across all steps of drug development and the SPHERE partnership to explore ideas around commercialising research into treatments, therapies or drugs to improve health across the community.

Leader of the Translational Cancer Metabolism Laboratory in the Adult Cancer Program at UNSW, A/Prof Jeff Holst explained, “The take home message reiterated by many speakers was that we need to fail fast by doing the right commercial grade assays early in our drug development pipeline. This will save time and money and ensure we develop the best drug candidate.”

Ongoing opportunities to connect

A Therapeutic Development Special Interest Group has also been formed and will be used to communicate future events and opportunities of interest, including a MedTech workshop planned in 2020. If you wish to be included, sign up here.

Watch the full video of the 2019 workshop which also includes a handy shortcut table to take you to the speaker or section you want to view or read more about the event.

 

Thank you again to our workshop convenors and facilitator: A/Prof. Jeff Holst (UNSW), A/Prof. Phoebe Phillips (UNSW), A/Prof. Greg Arndt (CCIA), Dr Stephen Palmer (UNSW), Prof. Mary Bebawy (UTS)

We also acknowledge UNSW Medicine, Cancer CAG, Maridulu Budyari Gumal, and UNSW Knowledge Exchange who provided funding for the workshop.  

Tags